EDT

EQS-News: Heidelberg Pharma announces financial figures and reports on successful business performance in 2023

Retrieved on: 
Wednesday, April 10, 2024
Malignancy, Spanish mythology, State university system, Patient, Sale, Renal cell carcinoma, Clinical trial, Neoplasm, Therapy, Depreciation, HPHA, USD, Marketing, GLP, Health, Research, ATACS, EPO, Immune system, ADC, BLA, ATAC, Food, Biologics license application, Disease, Magenta, Multiple myeloma, AACR, GCC, Annual report, FDA, Diagnosis, EUR, Supervisory board, Accounting, PET, EDT, Spacecraft, Amanitin, European Patent Convention, Patent, Eli Lilly and Company, Binghamton University, Pharmaceutical industry

Minority interest in Emergence sold: In summer 2023, Heidelberg Pharma sold its minority interest in Emergence Therapeutics AG, Duisburg, Germany, (Emergence).

Key Points: 
  • Minority interest in Emergence sold: In summer 2023, Heidelberg Pharma sold its minority interest in Emergence Therapeutics AG, Duisburg, Germany, (Emergence).
  • As a result, Heidelberg Pharma lost sales revenue in the low single-digit millions for the 2023 financial year.
  • In April 2023, Heidelberg Pharma signed a termination agreement with Magenta under which all licensed ATAC rights and some Magenta patents were assumed by Heidelberg Pharma.
  • The Heidelberg Pharma Group includes two entities, Heidelberg Pharma AG and Heidelberg Pharma Research GmbH.

EQS-News: MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Wednesday, April 10, 2024
Novartis, ASH, Tafasitamab, Webcast, Purchasing, EZH1, EDT, Acquisition, Standard of care, BET, Business analyst, EZH2, Ruxolitinib, Exposition, Society, Safety, Anemia, GMT, MorphoSys, JAK, Annual general meeting, Pharmaceutical industry

“Now, in 2024, we are pleased that Novartis is committing to the future of our promising pipeline.

Key Points: 
  • “Now, in 2024, we are pleased that Novartis is committing to the future of our promising pipeline.
  • With its ample resources, additional scientific expertise and global footprint, Novartis can help accelerate pelabresib's potential worldwide.
  • Total revenues for the fourth quarter 2023 were € 59.0 million compared to € 81.6 million for the same period in 2022.
  • The decrease resulted first and foremost from prior year revenues stemming from the execution of an out-licensing agreement with Novartis.

NOVONIX Announces Participation in April Investor Events

Retrieved on: 
Tuesday, April 9, 2024
USN, RET, Admiral, AGM, ASX, AEST, EDT, NVX

BRISBANE, Australia, April 10, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading battery materials and technology company, today announced that members of the executive team are scheduled to participate in the following upcoming investor events in April 2024:

Key Points: 
  • BRISBANE, Australia, April 10, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading battery materials and technology company, today announced that members of the executive team are scheduled to participate in the following upcoming investor events in April 2024:
    NOVONIX’s Annual General Meeting will be held in Brisbane, Australia on April 17th, details for participation can be found at the designated AGM webpage ;
    Dr. Chris Burns, CEO of NOVONIX, will provide prepared remarks in a business update webcast for the quarter-ended March 31st, 2024.
  • The webcast link and presentation materials will be available Wednesday, April 17th at 8:30 am AEST or Tuesday, April 16th at 6:30 pm EDT;
    Maxim Group is hosting their International Mining Collaboration: The World Needs More Mining & Processing virtual conference on April 23rd with NOVONIX participating at 11:30 am EDT; and
    Janney Montgomery Scott Virtual CEO Fireside Chat, April 24th at 1:00 pm EDT.
  • This announcement has been authorized for release by NOVONIX Chairman, Admiral Robert J. Natter, USN Ret.

Kinross to announce Q1 results on May 7, 2024

Retrieved on: 
Tuesday, April 9, 2024
EDGAR, Annual general meeting, KGC, EDT, York Street, Shareholder, Bank statement, TSX, Annual report, Kinross Gold

TORONTO, April 09, 2024 (GLOBE NEWSWIRE) -- Kinross Gold Corporation (TSX:K; NYSE:KGC) will release its financial statements and operating results for the first quarter of 2024 on Tuesday, May 7, 2024, after market close. On Wednesday, May 8, 2024, at 7:45 a.m. EDT Kinross will hold a conference call and audio webcast to discuss the results, followed by a question-and-answer session. The call-in numbers are as follows:

Key Points: 
  • TORONTO, April 09, 2024 (GLOBE NEWSWIRE) -- Kinross Gold Corporation (TSX:K; NYSE:KGC) will release its financial statements and operating results for the first quarter of 2024 on Tuesday, May 7, 2024, after market close.
  • On Wednesday, May 8, 2024, at 7:45 a.m. EDT Kinross will hold a conference call and audio webcast to discuss the results, followed by a question-and-answer session.
  • The link to the virtual meeting will also be accessible at www.kinross.com and will be archived for later use.
  • Shareholders may also receive a copy of Kinross’ audited financial statements without charge upon request to Kinross Gold’s Investor Relations Department, 25 York Street, 17th Floor, Toronto, Ontario, Canada, M5J 2V5 or to [email protected] .

BellRing Brands Schedules Second Quarter Fiscal Year 2024 Conference Call

Retrieved on: 
Tuesday, April 9, 2024
Post Holdings, Conference, Interest, EDT

ST. LOUIS, April 09, 2024 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) today announced it will hold a conference call on Tuesday, May 7, 2024 at 9:00 a.m. EDT to discuss financial results for the second quarter of fiscal year 2024 and fiscal year 2024 outlook and to respond to questions.

Key Points: 
  • ST. LOUIS, April 09, 2024 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) today announced it will hold a conference call on Tuesday, May 7, 2024 at 9:00 a.m. EDT to discuss financial results for the second quarter of fiscal year 2024 and fiscal year 2024 outlook and to respond to questions.
  • BellRing also announced it plans to release its financial results for the second quarter after market close on Monday, May 6, 2024.
  • Interested parties may join the conference call by registering in advance at the following link: BellRing Q2 2024 Earnings Conference Call .
  • Upon registration, participants will receive a dial-in number and a unique passcode to access the conference call.

Sysco to Announce Third Quarter Fiscal Year 2024 Financial Results on April 30

Retrieved on: 
Tuesday, April 9, 2024
SYY, Sysco, Webcast, Publishing, EDT, News

HOUSTON, April 09, 2024 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) will host a conference call and webcast to discuss its third quarter fiscal year 2024 financial results at 10 a.m. EDT on Tuesday, April 30, 2024.

Key Points: 
  • HOUSTON, April 09, 2024 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) will host a conference call and webcast to discuss its third quarter fiscal year 2024 financial results at 10 a.m. EDT on Tuesday, April 30, 2024.
  • All interested parties are invited to listen online at investors.sysco.com .
  • Prior to the conference call and webcast, the company will also issue a news release and post a slide presentation in the investor relations section of its website.
  • A replay of the webcast will be available online shortly after the live webcast is completed.

MariMed Announces First Quarter 2024 Earnings Date

Retrieved on: 
Monday, April 8, 2024
Webcast, OTCQX, EDT

NORWOOD, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced today it will report first quarter 2024 financial results on May 8, 2024 after the markets close.

Key Points: 
  • NORWOOD, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced today it will report first quarter 2024 financial results on May 8, 2024 after the markets close.
  • Management will host a conference call on May 9, 2024 at 8:00 a.m. EDT to discuss financial results.
  • A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q124 Earnings Webcast .
  • A playback of the call will also be made available on MariMed’s Investor Relations website.

Watsco’s Earnings Call to Discuss First Quarter Results Scheduled on April 24, 2024

Retrieved on: 
Monday, April 8, 2024
Watsco, PIN, WSO, EDT, CCBN

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Watsco, Inc. (NYSE: WSO) announced today that it will host a conference call to discuss its 2024 first quarter financial results on Wednesday, April 24, 2024 at 10:00 a.m. (EDT).

Key Points: 
  • MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Watsco, Inc. (NYSE: WSO) announced today that it will host a conference call to discuss its 2024 first quarter financial results on Wednesday, April 24, 2024 at 10:00 a.m. (EDT).
  • Prepared remarks regarding the results will be followed by a question-and-answer session with the senior management team.
  • The conference call will be web-cast by CCBN's StreetEvents and can be found under the link highlighted on our website at www.watsco.com .
  • The earnings results will be released before the market opens on April 24, 2024.

Rivalry Reports Preliminary Fourth Quarter and Year-End 2023 Results

Retrieved on: 
Friday, April 5, 2024
Fantasy, Growth, Entrepreneurship, Minority, Webcast, KPI, EDT, Acquisition, Bank statement, TAM, Generation Z, Finance Secretary (India), Traction, Ecosystem, Elasticity, NBA, Marketing, IOS, Multilateral, Gen

Rivalry is seeing a rise in demand to license its in-house casino games, accelerating the advancement of its B2B vertical.

Key Points: 
  • Rivalry is seeing a rise in demand to license its in-house casino games, accelerating the advancement of its B2B vertical.
  • TORONTO, April 05, 2024 (GLOBE NEWSWIRE) -- Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), the leading sportsbook and iGaming operator for Gen Z, today announced preliminary and unaudited financial results for the three and 12-month periods ended December 31, 2023.
  • “Rivalry exited 2023 as an increasingly diversified company – both geographically and across our product suite,” said Steven Salz, Co-Founder and CEO of Rivalry.
  • Management will host a conference call at 10:00 a.m. EDT on Friday, April 5, 2024 to discuss the Company’s preliminary unaudited year-end and fourth quarter 2023 financial results.

Carlyle Aviation Partners’ Fly Leasing Announces Fourth Quarter 2023 Financial Results and Schedules Investor Call

Retrieved on: 
Thursday, April 4, 2024
Ideal, EDT

MIAMI and DUBLIN, Ireland and SINGAPORE, April 04, 2024 (GLOBE NEWSWIRE) -- Fly Leasing Limited (“Fly Leasing”), a subsidiary of SASOF V which is managed by an affiliate of Carlyle Aviation Partners Ltd., today announced that has released financial results for the fourth quarter of 2023 and will host a conference call on April 15, at 9:00 a.m. EDT.

Key Points: 
  • MIAMI and DUBLIN, Ireland and SINGAPORE, April 04, 2024 (GLOBE NEWSWIRE) -- Fly Leasing Limited (“Fly Leasing”), a subsidiary of SASOF V which is managed by an affiliate of Carlyle Aviation Partners Ltd., today announced that has released financial results for the fourth quarter of 2023 and will host a conference call on April 15, at 9:00 a.m. EDT.
  • The conference call will be posted on the reporting site hosted by iDeals and a replay will be available on the platform for two weeks following the call’s completion.
  • To view the full call notification, review the quarterly financial results and participate in the conference call, please log onto the iDeals reporting site at: https://www4.idealsvdr.com/v3/Fly_Financials_Reporting .
  • 3) Upon completing set-up, you will be directed to the data room located at the following link: https://www4.idealsvdr.com/v3/Fly_Financials_Reporting